Skip to main content

Prevention of Cardiogenic Shock After Acute Myocardial Infarction.

Publication ,  Journal Article
Vanhaverbeke, M; Bogaerts, K; Sinnaeve, PR; Janssens, L; Armstrong, PW; Van de Werf, F
Published in: Circulation
January 2, 2019

Duke Scholars

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

January 2, 2019

Volume

139

Issue

1

Start / End Page

137 / 139

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time-to-Treatment
  • Time Factors
  • Thrombolytic Therapy
  • Shock, Cardiogenic
  • ST Elevation Myocardial Infarction
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Percutaneous Coronary Intervention
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vanhaverbeke, M., Bogaerts, K., Sinnaeve, P. R., Janssens, L., Armstrong, P. W., & Van de Werf, F. (2019). Prevention of Cardiogenic Shock After Acute Myocardial Infarction. Circulation, 139(1), 137–139. https://doi.org/10.1161/CIRCULATIONAHA.118.036536
Vanhaverbeke, Maarten, Kris Bogaerts, Peter R. Sinnaeve, Luc Janssens, Paul W. Armstrong, and Frans Van de Werf. “Prevention of Cardiogenic Shock After Acute Myocardial Infarction.Circulation 139, no. 1 (January 2, 2019): 137–39. https://doi.org/10.1161/CIRCULATIONAHA.118.036536.
Vanhaverbeke M, Bogaerts K, Sinnaeve PR, Janssens L, Armstrong PW, Van de Werf F. Prevention of Cardiogenic Shock After Acute Myocardial Infarction. Circulation. 2019 Jan 2;139(1):137–9.
Vanhaverbeke, Maarten, et al. “Prevention of Cardiogenic Shock After Acute Myocardial Infarction.Circulation, vol. 139, no. 1, Jan. 2019, pp. 137–39. Pubmed, doi:10.1161/CIRCULATIONAHA.118.036536.
Vanhaverbeke M, Bogaerts K, Sinnaeve PR, Janssens L, Armstrong PW, Van de Werf F. Prevention of Cardiogenic Shock After Acute Myocardial Infarction. Circulation. 2019 Jan 2;139(1):137–139.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

January 2, 2019

Volume

139

Issue

1

Start / End Page

137 / 139

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time-to-Treatment
  • Time Factors
  • Thrombolytic Therapy
  • Shock, Cardiogenic
  • ST Elevation Myocardial Infarction
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Percutaneous Coronary Intervention
  • Humans